Entering text into the input field will update the search result below

Seattle Genetics EPS beats by $0.13, beats on revenue

Jul. 29, 2021 4:10 PM ETSeagen Inc. (SGEN) StockSGENBy: Gaurav Batavia, SA News Editor4 Comments
  • Seattle Genetics (NASDAQ:SGEN): Q2 GAAP EPS of -$0.47 beats by $0.13.
  • Revenue of $388.5M (+39.7% Y/Y) beats by $30.8M.
  • 2021 Guidance: Re-affirmed ADCETRIS sales of $675M-$700M vs. $658.6M in FY20; Re-affirmed PADCEV sales of $310M-$325M vs. $222.4 in FY20; Re-affirmed TUKYSA sales of $300M-$315M vs. $119.6M in FY20; Re-affirmed royalty revenues of $125M-$135M vs. $126.7M in

Recommended For You

Related Stocks

SymbolLast Price% Chg
SGEN--
Seagen Inc.